Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2021 Nov 22

PMID 34803391

Citations 12

Authors

Yaqin Zhang

Lan Wang

Dickson Kofi Wiredu Ocansey

Bo Wang

Li Wang

Zhiwei Xu

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD), which affects about 7 million people globally, is a chronic inflammatory condition of the gastrointestinal tract caused by gut microbiota alterations, immune dysregulation, and genetic and environmental factors. The association of microbial and immune molecules with mucin-type O-glycans has been increasingly noticed by researchers. Mucin is the main component of mucus, which forms a protective barrier between the microbiota and immune cells in the colon. Mucin-type O-glycans alter the diversity of gastrointestinal microorganisms, which in turn increases the level of O-glycosylation of host intestinal proteins via the utilization of glycans. Additionally, alterations in mucin-type O-glycans not only increase the activity and stability of immune cells but are also involved in the maintenance of intestinal mucosal immune tolerance. Although there is accumulating evidence indicating that mucin-type O-glycans play an important role in IBD, there is limited literature that integrates available data to present a complete picture of exactly how O-glycans affect IBD. This review emphasizes the roles of the mucin-type O-glycans in IBD. This seeks to provide a better understanding and encourages future studies on IBD glycosylation and the design of novel glycan-inspired therapies for IBD.

Citing Articles

Fish MicroRNA Responses to Thermal Stress: Insights and Implications for Aquaculture and Conservation Amid Global Warming.

Lin T, Meegaskumbura M Animals (Basel). 2025; 15(5).

PMID: 40075907 PMC: 11898199. DOI: 10.3390/ani15050624.

Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism.

Zhao Q, Zhou S, Lou W, Qian H, Xu Z Cell Death Differ. 2025; .

PMID: 40045035 DOI: 10.1038/s41418-025-01473-z.

Effects of Fasting on Metabolic Hormones and Functions: A Narrative Review.

Fink J, Tanaka M, Horie S Juntendo Iji Zasshi. 2024; 70(5):348-359.

PMID: 39545228 PMC: 11560338. DOI: 10.14789/jmj.JMJ24-0012-R.

Preventative Effects of Milk Fat Globule Membrane Ingredients on DSS-Induced Mucosal Injury in Intestinal Epithelial Cells.

Kosmerl E, Miller C, Jimenez-Flores R Nutrients. 2024; 16(7).

PMID: 38612988 PMC: 11013169. DOI: 10.3390/nu16070954.

alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier.

Bai D, Zhao J, Wang R, Du J, Zhou C, Gu C Acta Pharm Sin B. 2024; 14(4):1677-1692.

PMID: 38572095 PMC: 10985029. DOI: 10.1016/j.apsb.2023.12.015.

References

Vogt S, Pena-Diaz J, Finlay B . Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe. 2015; 34:106-15. DOI: 10.1016/j.anaerobe.2015.05.002. View

Luijkx Y, Bleumink N, Jiang J, Overkleeft H, Wosten M, Strijbis K . Bacteroides fragilis fucosidases facilitate growth and invasion of Campylobacter jejuni in the presence of mucins. Cell Microbiol. 2020; 22(12):e13252. PMC: 7685106. DOI: 10.1111/cmi.13252. View

Corfield A, Berry M . Glycan variation and evolution in the eukaryotes. Trends Biochem Sci. 2015; 40(7):351-9. DOI: 10.1016/j.tibs.2015.04.004. View

Karasawa F, Shiota A, Goso Y, Kobayashi M, Sato Y, Masumoto J . Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest. 2012; 122(3):923-34. PMC: 3287219. DOI: 10.1172/JCI59087. View

Ohnmacht C, Park J, Cording S, Wing J, Atarashi K, Obata Y . MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells. Science. 2015; 349(6251):989-93. DOI: 10.1126/science.aac4263. View

Moran A, Gupta A, Joshi L . Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut. 2011; 60(10):1412-25. DOI: 10.1136/gut.2010.212704. View

Carrascal M, Severino P, Cabral M, Silva M, Ferreira J, Calais F . Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Mol Oncol. 2014; 8(3):753-65. PMC: 5528624. DOI: 10.1016/j.molonc.2014.02.008. View

Marcobal A, Barboza M, Sonnenburg E, Pudlo N, Martens E, Desai P . Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe. 2011; 10(5):507-14. PMC: 3227561. DOI: 10.1016/j.chom.2011.10.007. View

Ramamurthy T, Nandy R, Mukhopadhyay A, Dutta S, Mutreja A, Okamoto K . Virulence Regulation and Innate Host Response in the Pathogenicity of . Front Cell Infect Microbiol. 2020; 10:572096. PMC: 7554612. DOI: 10.3389/fcimb.2020.572096. View

10.

Katoh T, Ojima M, Sakanaka M, Ashida H, Gotoh A, Katayama T . Enzymatic Adaptation of to Host Glycans, Viewed from Glycoside Hydrolyases and Carbohydrate-Binding Modules. Microorganisms. 2020; 8(4). PMC: 7232152. DOI: 10.3390/microorganisms8040481. View

11.

Spor A, Koren O, Ley R . Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011; 9(4):279-90. DOI: 10.1038/nrmicro2540. View

12.

Xia L, Ju T, Westmuckett A, An G, Ivanciu L, McDaniel J . Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol. 2004; 164(3):451-9. PMC: 2172228. DOI: 10.1083/jcb.200311112. View

13.

Nakayama J, Yeh J, Misra A, Ito S, Katsuyama T, Fukuda M . Expression cloning of a human alpha1, 4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1-->4Galbeta-->R, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci U S A. 1999; 96(16):8991-6. PMC: 17720. DOI: 10.1073/pnas.96.16.8991. View

14.

Cooke C, An H, Kim J, Canfield D, Torres J, Lebrilla C . Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology. 2009; 137(3):1061-71, 1071.e1-8. DOI: 10.1053/j.gastro.2009.04.014. View

15.

Gurram R, Zhu J . Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses. Cell Mol Immunol. 2019; 16(3):225-235. PMC: 6460501. DOI: 10.1038/s41423-019-0210-8. View

16.

Salzman N, Ghosh D, Huttner K, Paterson Y, Bevins C . Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003; 422(6931):522-6. DOI: 10.1038/nature01520. View

17.

Johansson M, Thomsson K, Hansson G . Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res. 2009; 8(7):3549-57. DOI: 10.1021/pr9002504. View

18.

Koropatkin N, Cameron E, Martens E . How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012; 10(5):323-35. PMC: 4005082. DOI: 10.1038/nrmicro2746. View

19.

De Weirdt R, Van de Wiele T . Micromanagement in the gut: microenvironmental factors govern colon mucosal biofilm structure and functionality. NPJ Biofilms Microbiomes. 2017; 1:15026. PMC: 5515210. DOI: 10.1038/npjbiofilms.2015.26. View

20.

Johansson M, Gustafsson J, Holmen-Larsson J, Jabbar K, Xia L, Xu H . Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2013; 63(2):281-91. PMC: 3740207. DOI: 10.1136/gutjnl-2012-303207. View